A single shot that appears to regrow worn knee cartilage and head off arthritis sounds like science fiction, yet early data ...
Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.